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Abstract 
In vertebrates, androgens are responsible for male primary and secondary sexual 
characteristics and behavior. Androgens exert their functions by interacting with the 
androgen receptor. This signaling pathway can be disrupted by exogenous chemicals 
that can either mimic or antagonize the actions of the hormones. In this study, the 
subcellular localization of androgen receptor from Zebrafish (Danio rerio) (zfAR) 
was studied by expressing the yellow fluorescence protein (YFP)-zfAR fusion protein 
in Hela and ZFL cell lines. Unliganded zfAR resides relatively even between 
cytoplasm and nucleus, and it undergoes nuclear translocation in response to the 
binding of ligands such as 11-ketotestorsterone (11-KT) and dihydrotestosterone 
(DHT). Mutations created by site-directed mutagenesis in the predicted nuclear 
localization sequence (KKCFEVGMTLGARKLRK) severely destroyed the 11-KT 
induced nuclear translocation of zfAR. Furthermore, environmental antiandrogenic 
chemicals bisphenol A, p, p’-DDE, vinclozolin and fenitrothion did not induce nuclear 
translocation of zfAR alone, but significantly inhibited the 11-KT induced nuclear 
import of zfAR at concentration 10-6M. Combinational effects of these four chemicals 
were larger than effects observed with single chemical, but no cumulative effects 
could be concluded in this study. 
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Abbreviations and definitions 
11-KT: 11-ketotestosterone  
ADC(s): Androgen Disrupting Chemical(s) 
ARE: Androgen Response Element 
BPA: Bisphenol A 
DBD: DNA binding Domain 
DHT: 5α-dihydrotestosterone  
DMSO: dimethyl sulfoxide 
EDC(s): Endocrine Disrupting Chemical(s) 
FSH: Follicle Stimulating Hormone  
hAR: human Androgen Receptor  
LBD: Ligand Binding Domain 
NLS: Nuclear Localization Sequence 
NES: Nuclear Export Signal 
SHBG: Sex Hormone Binding Globulin 
T: Testosterone  
TEF: Toxic Equivalency Factor 
YFP: Yellow Fluorescence Protein 
zfAR: zebrafish Androgen Receptor 
 10
 11
Introduction 
Despite extensive differences in sex determination and in sexual development and 
function between different types of vertebrates (fish, amphibians, birds, reptiles and 
mammals), some mechanisms are common, namely the involvement of androgens 
and estrogens in development and function of male and female primary and 
secondary sexual characteristics and behavior. The function of these steroids can be 
disrupted by exogenous chemicals that can either mimic or antagonize their actions. 
Therefore, environmental releases of industrially and agriculturally generated 
contaminants represent considerable risk in human and wildlife health. A battery of 
tests screening for endocrine disrupting potential among the existing and newly 
generated chemicals was recommended by the Endocrine Disrupter Screening and 
Testing Advisory Committee (EDSTAC) (1998) convened by the U.S. Environmental 
Protection Agency (EPA), and by an OECD (Organization for Economic Co-operation 
and Development) working group (EDTA-Endocrine Disrupter Testing and 
Assessment Task Force).Understanding the signaling pathways of the steroids is the 
first step towards a fair risk assessment of potential Endocrine Disrupting Chemicals 
(EDCs).  
1. Androgen and Androgen receptor 
In vertebrates, the seminiferous tubules are lined with germ cells and Sertoli cells. 
Follicle-stimulating hormone (FSH) released from anterior pituitary binds to its 
receptors on Sertoli cells and consequently stimulates spermatogenesis in the germ 
cells after sexual maturity. Sertoli cells support the development of the sperm and are 
responsible for androgen receptor synthesis. Between the seminiferous tubules, 
Leydig cells produce and secrete androgens, especially testosterone. 
The androgens are responsible for triggering development of the primary male sexual 
characteristics in the embryo, and the secondary male sexual characteristics at the 
time of puberty. The androgens also contribute to general growth, i.e. the synthesis of 
myofibrillar proteins in muscle, and male psychological and behavioral changes. 
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1.1 Androgen signaling 
Steroids hormone are delivered to their target sites through endocrine, paracrine and 
autocrine secretion. Circulating steroids rapidly reach equilibrium among different 
body fluid compartments. About 98% of the lipophilic steroid hormones are 
transported by sex hormone binding globulin (SHBG) and 2% of the steroid 
hormones are circulating free and thus are biologically active (You 2004).  
The basic mode of action for sex steroids is to interact with ligand-specific 
intracellular nuclear receptors. The activated nuclear receptors bind to hormone 
response elements upstream structural genes and alter their rates of transcription. 
These actions of steroids are thus genomic, which are typically slow. Steroid 
hormones also exert rapid cellular actions that, with or without the involvement of 
their nuclear receptors, do not require alteration in gene expression and it is therefore 
termed the non-genomic activity.  
Both genomic and nongenomic pathways play important roles in androgen signaling. 
Nongenomic action of androgens can be mediated through membrane or membrane 
associated androgen receptor/binding proteins, changes in membrane flexibility, 
changes in Ca2+, activation of second messenger pathway or a combination of these 
mechanisms [reviewed by (Feldman and Feldman 2001; Foradori et al. 2008; 
Heinlein and Chang 2002; Michels and Hoppe 2008)]. In the genomic pathway, free 
testosterone enters cells, and is immediately metabolized to the more potent androgen 
5α-dihydrotestosterone (DHT). DHT binds to the inactive nuclear androgen receptor. 
In many, but not all, cells in tissue culture, inactivated androgen receptor is 
predominantly cytoplasmic (Black and Paschal 2004). Upon ligand binding, androgen 
receptor undergoes a series of events including homodimerization, phosphorylation, 
and conformational change that allow the androgen receptor to enter the nucleus via 
an intrinsic nuclear localization signal. Inside the nucleus, AR interact with a specific 
sequence on DNA located upstream the promoter termed Androgen Response 
Element (ARE) (Feldman and Feldman 2001; Hirawat et al. 2003; Roy et al. 2001) 
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(figure 1). This interaction facilitates the downstream gene transcription by recruiting 
numbers of coregulator proteins such as CBP, p300, and other nuclear receptor 
coactivateor pCAF, SRCI and SRC3. Ultimately RNA Pol II is recruited and bind to 
the promoter of target genes [reviewed in (Culig et al. 2003; Lee and Chang 2003a)].  
 
Figure 1. Genomic pathway of androgen signaling. Free testosterone enters cells, and is 
immediately metabolized to the more potent androgen 5α-dihydrotestosterone (DHT). DHT 
binds to the inactive nuclear androgen receptor. Upon ligand binding, androgen receptor 
undergoes a series of events including homodimerization, phosphorylation, and 
conformational change that allow the androgen receptor to enter the nucleus. AR interacts with 
androgen response element and facilitates the downstream gene transcription. Picture 
adapted from (Feldman and Feldman 2001). 
 
1.2 Nuclear import of androgen receptor 
The genomic pathway of androgen signaling is mediated through the nuclear 
androgen receptor(s). Nuclear androgen receptors are members of the steroid receptor 
superfamily of ligand-dependent transcription factors that generally consist of an 
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amino-terminal hypervariable transcriptional activation domain, a central highly 
conserved DNA-binding domain (DBD), and a C-terminal ligand-binding domain 
(LBD). DBD and LBD are connected by a hinge region (Hirawat et al. 2003; Roy et 
al. 2001).  
Nuclear translocation of AR is one of the critical steps, and this ligand-dependent 
import of AR is regulated by several coregulators and an intrinsic nuclear localization 
sequence (NLS). The first identified NLS motif was that of the SV40 large T-antigen 
(PKKKRKV). A typical SV40-like NLS is a small sequence of seven or eight amino 
acids containing a single cluster of basic residues. This type of NLS is simple and 
usually sufficient in inducing nuclear transport (LaCasse and Lefebvre 1995). 
Mutagenesis studies of human androgen receptor (hAR) revealed that it contains 
another type of NLS, the bipartite type (Zhou et al. 1994), which is more complex and 
more dependent on other functional domains in the protein compared to the first type 
of NLS (Saporita et al. 2003) . For example, the phosphorylation of the specific site X 
in hAR stabilizes the ligand/receptor homodimer, marking the ligand-receptor 
complex for translocation to the nucleus (Edwards and Bartlett 2005; Lee and Chang 
2003b; Zhu et al. 2001). A bipartite nuclear targeting sequence consists of two 
clusters of basic amino acids separated by 10 amino acids, e.g. 
RKCYEAGMTLGARKLKK in hAR (Zhou et al. 1994). The C-terminal basic 
sequence is similar to the NLS of SV40 large T-antigen. However, both basic clusters 
are essential for efficient nuclear import. In hAR, the NLS locates in the DNA binding 
and hinge regions at amino acids 617-633, and is modulated by interactions between 
the NH2- and carboxyl-terminal regions (Zhou et al. 1994).  
In human cells, inactivated androgen receptors are bound by chaperone proteins such 
as heat-shock protein 70 (Hsp 70) and Hsp 90 in cytoplasm. Upon ligand binding, the 
androgen receptor undergoes conformational changes that expose the NLS. The 
exposed NLS can be recognized by import machinery such as importin-α, which, with 
importin-β, mediates docking interaction onto the nuclear-pore complex. 
Translocation of the receptor complex through the nuclear membrane is inferred to 
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directly interact with the RanGTP (Paschal 2002; Roy et al. 2001).  
1.3 Androgen receptor subnuclear localization 
Localization studies of GFP chimeras of AR show that the subnuclear distribution of 
the protein adopts a punctuate pattern which are commonly referred to as “nuclear 
foci” (Black and Paschal 2004; Roy et al. 2001; Tomura et al. 2001). The 
hyperspeckled distribution of agonist-bound GFP-AR is clearly correlated with both 
decreased solubility and mobility (Marcelli et al. 2006). Fluorescence image and 
three-dimensional reconstruction studies suggested that the agonist-bound AR is 
localized between euchromatin and heterochromatin, which gives rise to nuclear foci 
numbering between 250 and 400 (Tomura et al. 2001). The formation of foci is 
dependent on agonist binding of AR. In contrast, antagonist bound AR is distributed 
more uniformly throughout the nucleus (Karvonen et al. 2002). The underlying 
composition of this subnuclear compartment is shown to be associated with the ability 
of agonist bound AR to interact with other transcription co-activator, such as CBP and 
p160 (Black and Paschal 2004; Karvonen et al. 2002; Marcelli et al. 2006). This is 
also confirmed by the fact that flutamide-bound AR (flutamide is a pharmaceutical 
antiandrogen) does not have transactivity for downstream genes, even though nuclear 
translocation occurs but fails to form nuclear foci. Therefore, nuclear foci represent 
transcriptionally active forms of the receptor while homogeneous receptor distribution 
represents transcriptionally inactive forms (Kumar et al. 2006). The agonist binding 
of AR has significant influence on normal function of AR as it specifically initiates a 
complex cascade of events that include nuclear translocation, hyperspeckle formation, 
and co-activator recruitment (Marcelli et al. 2006). 
1.4 Zebrafish androgen receptor and androgen signaling 
1.4.1 Androgen signaling in fish 
Knowledge about androgen signaling in teleost fish is currently very limited. In fish, 
11-ketotestosterone, testosterone and androstenedione are the main functional 
 16
androgens and it is believed that the action of androgens is primarily mediated 
through the classic genomic pathway by binding to intracellular androgen receptors. 
At the same time, the nongenomic signal pathway has also been described in specific 
functions (fx oocyte maturation) in some fish and amphibian species (Braun and 
Thomas 2004; White et al. 2005). 
Until now androgen receptors from many fishes have been cloned, including 
zebrafish, Atlantic croaker, mosqitofish, three-spine stickleback, fathead minnow etc. 
Both membrane AR and nuclear AR have been discovered (Braun and Thomas 2004; 
White et al. 2005). While in some fish species two types of AR have been described, 
in other species, only one type of AR has been discovered. When two ARs have been 
identified in the same specie, the ARs can differ from each other in several ways 
including tissue expression, physiological functions, specificity in binding ligands and 
mechanism of action.  
1.4.2 Characterization and structure of zebrafish androgen receptor  
Zebrafish androgen receptor gene (zfar) was firstly cloned and characterized by 
Jorgensen et al (2007) and Hossain et al. (2008) independently. In both studies, only a 
single ar locus was found. Blast results show that the single locus located at 
chromosome 5, and is 118.24 kb long and contains 13 exons (Hossain et al. 2008). 
The sequence analysis reveals that the zfAR has the three typical nuclear hormone 
receptors functional domains: an amino-terminal hypervariable transcriptional 
activation domain (TAD), a central highly conserved DNA-binding domain (DBD), 
and a C-terminal ligand-binding domain (LBD). A putative leucine zipper and two 
zinc fingers motifs located within the LBD contribute to the dimerization of receptors 
and DNA binding upon ligand binding (Hossain et al. 2008; Jorgensen et al. 2007).  
Tissue-specific expression analysis showed that the zfar was expressed ubiquitously 
in all adult tissues, with sexually dimorphic expression in the gonad and muscle. The 
ar transcript was maternally deposited into the embryo (Hossain et al. 2008).  
KT was found to be the most potent agonist of zebrafish AR among KT, DHT, T 
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(testosterone), A (androstenedione) and E2 (estradiol) in the gene expression assay 
(Hossain et al. 2008), even though DHT has the highest binding affinities in 
competition with 3H-T among DHT, KT, T and A (Jorgensen et al. 2007). 
Despite that zebrafish is an important model organism in developmental biology and 
ecotoxicology, the mechanism of sex determination and gonadal sex differentiation 
has not been elucidated. Several studies indicate the importance of androgen signaling 
in zebrafish sexual development (Kinnberg et al. 2007; Orn et al. 2003), but 
knowledge concerning the androgen molecular action is very limited. Thus it is 
interesting to study the role of zfAR in androgen signaling in order to understand 
more about the molecular mechanism of zebrafish sex differentiation. The 
investigation of the subcellular localization of zfAR will provide the first hint of 
androgen signaling in zebrafish. Based on the conservation of the androgen signaling 
pathway among different species, our hypothesis is that the inactivated zfAR locates 
in cytoplasm, and upon binding to its natural ligand zfAR undergoes nuclear 
translocation via an intrinsic NLS. To test our hypothesis, subcellular localization of 
zfAR was studied by tagging it to a yellow fluorescence protein (YFP), and the 
function of a hypothetical NLS within zfAR was studied using site-directed 
mutagenesis.  
2. Environmental Androgen Disrupting Chemicals (ADCs) 
An endocrine-disrupting chemical (EDC) is defined as “an exogenous substance or 
mixture that alters function(s) of the endocrine system and consequently produces 
adverse health effects in an intact organism, or its progeny or Populations” by the 
World Health Organization (2002). EDCs include some organic chemicals, as well as 
some metals used extensively in the past, especially in industry and agriculture. EDCs 
are found in many of the every day products we are currently using including plastic 
bottles, metal food cans, detergents, flame retardants, food, toys, cosmetics and 
pesticides, and therefore possibly represent a human risk. Besides synthetic sources, 
EDCs also have natural sources including human and animal hormones and phyto- 
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and mycoestrogens found in sewage, animal husbandry runoff, and intentionally or 
accidentally as food and feed ingredients (Goksoyr 2006). 
EDCs have diverse structures, but most of them and their metabolites share lipophilic 
and persistent nature. They accumulate and biomagnify in different environmental 
compartments, including aquatic biota. Many of these chemicals have been linked 
with developmental, reproductive, neural, immune, and other problems in wildlife.  
According to the phenomenological similarities caused by EDCs and the most 
frequently studied hormone receptors, EDCs can be roughly divided into the 
following groups: estrogenic chemicals (e.g. diethylstilbestrol), antiandrogens (e.g. 
vinclozolin), thyroid-disrupting chemicals (e.g. PCDDs and PCBs) and AhR agonists 
(e.g. the dioxin-like chemicals and some PCBs) (Kortenkamp 2007). 
In the aquatic environment, chemicals with estrogenic activity have been the focus of 
a great number of studies (Brevini et al. 2005; Goksoyr 2006; Sonnenschein and Soto 
1998). Many chemicals that were in extensive industrial and agricultural use have 
been banned or limited because of their endocrine disrupting potential, such as some 
PCBs.  
Since the early 1990’s, studies have revealed decreased semen quality in Danish men  
and increased incidences of prostate cancer, hypospadia, and cryptorchidism 
(Andersen et al. 2000). Hereafter, chemicals known to disrupt androgen signaling 
pathways became a research hot spot, and this group of chemicals are therefore called 
androgen disrupting chemicals (ADCs) (Gray et al. 1994; Gray et al. 1999b; Kelce et 
al. 1995; Tamura et al. 2001; Vinggaard et al. 2006). In contrast to estrogens that 
feminize males, ADCs interfere with natural androgen functions and thereby cause 
malformation of male reproductive tissue or inhibition of development and function 
of male characteristics. In fact, some chemicals that had previously been shown to be 
estrogen agonists are also antiandrogens (Lee et al. 2003; Sohoni and Sumpter 1998). 
In some studies using a rodent model, the endpoints to detect antiandrogenic effects 
after in utero exposure of male rats include changes in the anogenital distance 
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(distance between penis and anus), retained nipples, and alteration in the weight of 
sexual organs and accessory glands. Another assay used for screening 
(anti)androgenic compound is the Hershberger assay where the weights of male 
reproductive tract tissues are measured after in vivo exposure (Christiansen et al. 2008; 
Gray et al. 1999a; Gray et al. 1994; Gray et al. 1999b; Hass et al. 2007; Metzdorff et 
al. 2007; Rider et al. 2008). Classes of chemicals currently known to interfere with 
the androgen signaling pathways include dicarboximide fungicides (e.g.vinclozolin), 
organochlorine-based insecticides (e.g. p,p’-DDE), organophosphate insecticide (e.g. 
fenitrothion), conozole fungicides (prochloraz), plasticizers (phthalates, BPA), and 
urea-based herbicides (linuron) (Wilson et al. 2008). 
Many of these androgen disrupting chemicals are found not only to antagonize 
androgen functions in mammals, but also in other vertebrates, including fishes 
(Arukwe 2001; Bayley et al. 2003; Kinnberg et al. 2007; Kiparissis et al. 2003; Leon 
et al. 2007; Martinovic et al. 2008).  
2.1 Action mechanisms of ADCs  
Hormones are maintained through a dynamic balance between steroidogenesis and 
steroid inactivation to ensure their physiological function. Although many steps of the 
sensitive endocrine regulatory system can be influenced by different external stimuli, 
most effects of endocrine disruptors observed and explained until now are attributed 
to the function of the gonads, which control the development of sexual differentiation, 
secondary sex characteristics, and functioning of sex organs (Goksoyr 2006). As 
presented before, physiological functions of sexual hormones are largely mediated 
through the activation of ligand-specific steroid hormone receptors. Therefore, 
exogenous compounds can disrupt normal hormonal functioning by either interacting 
with the receptors or altering ligands bioavailability through interfering with steroid 
hormones biosynthesis, transportation, action in target organs and the coordinated 
metabolism. Further, since endocrine homeostasis and hormone secretion require 
complex regulations and coordination, interference of exogenous compounds with 
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biosynthesis and metabolism of one particular hormone could indirectly interfere with 
other hormones via cross-talk of signal pathways or feedback regulation (You 2004).  
Androgen disrupting chemicals also work through multiple mechanisms. One of the 
major mechanisms for many of the antiandrogens that have been described to date is 
to directly interact with the androgen receptor and thereby interfere with functions of 
the natural androgen (Wilson et al. 2008). Since normal androgen signaling requires a 
series of events, interference from antiandrogenic chemicals could happen during any 
of the steps or a combination of several steps (Lee et al. 2003; Wilson et al. 2008). 
The mode of action for antiandrogens have primarily been verified through in vitro 
experiments such as receptor binding assays, subcellular localization studies of 
androgen receptors, and reporter gene assays (Kelce et al. 1995; Lee et al. 2003; Soto 
et al. 1998). Another group of antiandrogens, such as certain phthalates, does not 
antagonize the androgen receptor directly, but instead inhibits fetal testis hormone 
production including testosterone (Gray et al. 2006; Wilson et al. 2008). Some 
antiandrogens, as mentioned before, are also estrogen receptor agonists (Sohoni and 
Sumpter 1998). Thus antiandrogen is often used broadly in terms of counteracting the 
effects of androgens in a functional sense, as opposed to referring only to AR 
antagonists. However, this project mainly focuses on the narrow sense of 
antiandrogens, even though some of the chemicals used here may work in multiple 
modes of action. The structures of the four chosen antiandrogens are shown below:  
 
2.1.1 Bisphenol A (BPA) 
BPA is one of the industrial compounds that have attracted much attention because of 
its widespread use. It is a monomer used in polycarbonate plastic and polystyrene 
resins and as dental sealants. Harsh detergents, acidic or high temperature liquids 
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cause depolymerazation of the products resulting in leaching of BPA and its 
derivatives into foods, infant formula, and saliva etc. BPA was first known to elicit 
estrogenic activity by competing with estradiol for binding to the estrogen receptor 
and increased MCF-7 cell proliferation (Krishnan et al. 1993). Since then great 
attention has been raised concerning the influence of BPA on the environmental 
estrogen pool. Numerous in vitro and in vivo studies have focused on the potential of 
the compound to affect ER transactivation in human or yeast cells and to mimic the 
physiological function of natural estrogen in mammals (Gaido et al. 1997; Gould et al. 
1998; Kurosawa et al. 2002). Bisphenol A was verified as a weak estrogen receptor 
agonist (Gaido et al. 1997). However, in vivo studies show different physiological 
effects of bisphenol A compared to estradiol, and this leads to the conclusion that 
bisphenol A interacts with the estrogen receptor alpha in a distinct manner from 
estradiol (Gould et al. 1998). Further, in vitro studies found that Bisphenol A is also a 
human androgen receptor antagonist, an aryl hydrocarbon receptor (AhR) antagonist 
and an aromatase activity modulator (Bonefeld-Jorgensen et al. 2007; Lee et al. 2003; 
Nativelle-Serpentini et al. 2003; Xu et al. 2005). Thus BPA has the potential to affect 
several cellular pathways, including gene expression regulated by the steroid 
receptors ER and AR, the conversion of testosterone into estrogen by aromatase, and 
the function of AhR, involved in synthesis of steroids such as estrogens and 
metabolism of steroids and xenobiotic compounds (Bonefeld-Jorgensen et al. 2007). 
2.1.2. P, p’-DDE 
The p, p’-DDE (dichloro- diphenyldichloroethylene), a metabolite of the pesticide 
DDT, is one of the first identified antiandrogens (Kelce et al. 1995; Sohoni and 
Sumpter 1998). It is a well-known environmental pollutant that possesses estrogenic 
activity and accumulates in tissues because of slow metabolic degradation and 
excretion. Kelce et al. (1995) provided compelling evidence for its antiandrogenic 
effects from both in vitro and in vivo studies. In vitro, p, p’-DDE competitively binds 
to the rat androgen receptor, and blocks androgen-induced human AR mediated 
transcription activity. In developmental studies with the rat, p, p’-DDE exposed dams 
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gave birth to male pups that exhibited reduced anogenital distance and retained 
thoracic nipples (Kelce et al. 1995). Also, the onset of pubertal maturation was 
delayed in male rats treated with p, p’-DDE and the adult male rats had reduced 
androgen-dependent seminal vesicle and ventral prostate weights (Kelce et al. 1995). 
Increase in testosterone-repressed prostatic message 2 (TRPM-2) messenger RNA 
levels and a decline in androgen-induced prostate binding protein subunit 3 (C3) 
mRNA levels also support the proposed antiandrogen effects of p, p’-DDE (Kelce et 
al. 1995).  
2.1.3 Vinclozolin 
Vinclozolin is a fungicide used on food crops (soft fruits and vegetables). It is 
classified as a group C chemical (possible human carcinogen) by U.S. EPA, because 
of its antiandrogenic activity and association with prostate cancer. It is one of the 
environmental antiandrogens that has been studied the most until now, and no other 
mechanism than this has been suggested. It was first reported to cause antiandrogenic 
effects during male rat sexual differentiation (Gray et al. 1999a; Gray et al. 1994), and 
later in vitro studies found that not only vinclozolin itself competitively antagonized 
androgen binding, its two main degradation products, 2-[[(3,5-dichlorophenyl)- 
carbamoyl]oxy] -2-methyl-3-butenoic acid (M1) and 3',5'-dichloro-2-hydroxy-2- 
methylbut-3-enanilide (M2) are even more potent antagonists of rat and human 
androgen receptor binding (Kelce et al. 1994). In addition, M2 inhibits 
receptor-mediated transactivation in rats by blocking the binding of androgen-bound 
AR to the ARE on DNA (Kelce et al. 1997). Addition of vinclozolin to rat serum at 
37℃ resulted in more than 90% conversion to M1 and M2 within 2 hours. It is 
therefore suggested that the demasculinizing effects of vinclozolin exposure in vivo 
was mediated via the metabolites M1 and/or M2 (Kelce et al. 1994). Current in vivo 
evidence is mostly based on rodent models, and even though comparative physiology 
makes it very likely that humans respond to vinclozolin exposure like rodents, the 
only study based on human occupational exposure to vinclozolin for 1 to 13 years 
found no evidence of antiandrogenic or other reproductive effects (Zober et al. 1995).  
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In fathead minnow, the detection of the vinclozolin metabolites M1 and M2 is 
consistent with studies in rat (Makynen et al. 2000). However, inconsistent results 
have been reported regarding its antiandrogenic effects among fishes. Makynen et al. 
(2000) found no significant effects on reproduction at concentration as high as 1200 
µg/L in fathead minnow, while Martinovic et al. (2008) claimed to confirm 
antiandrogenic effects of vinclozolin in the same species, with decreased fecundity 
and expression of male secondary sexual characteristics in vinclozolin-exposed fish. 
Vinclozolin has also been found to cause antiandrogenic effects in male guppy 
(Bayley et al. 2003). Binding studies show that the binding affinity of vinclozolin to 
AR depends on the type of AR. In fathead minnow, vinclozolin, M1 and M2 had a 
low binding affinity to the putative androgen receptor in brain and gonadal extract 
(Makynen et al. 2000), but a high affinity for androgen receptor from some tissues in 
kelp bass and Atlantic croaker has been reported (Sperry and Thomas 1999). In a 
study on global gene expression profiling of androgen disruption in medaka, 
vinclozolin shared similar antiandrogenic expression profiles with flutamide, a 
prototypic antiandrogen (Leon et al. 2008).  
2.1.4 Fenitrothion 
The organophosphothioate pesticide fenitrothion (F), [0,0-dimethyl-0-(4-nitro-m-tolyl) 
phosphorothioate], is an organophosphate insecticide that has been widely used since 
1959 to control insects in agriculture and for flies, mosquito, and cockroach control in 
public health campaigns. As a result, the human health effects especially among 
applicators, gardeners, and farmers, associated with exposure to fenitrothion are of 
great concern. Tamura and colleagues (2001) recognized that fenitrothion shares 
structural similarities with the pharmaceutical antiandrogen flutamide and the 
environmental antiandrogenic herbicide linuron. Their preliminary work showed that 
fenitrothion is an antiandrogen in rat and its antiandrogenic activity was proved by in 
vitro assays (Tamura et al. 2001). Fenitrothion competitively antagonize 
DHT-dependent hAR activation in a luciferase reporter assay in HepG2 cells, and it 
significantly reduced weights of accessory sex glands in Hershberger assay (Tamura 
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et al. 2001). It is also found to be an antiandrogen in three-spined stickleback 
(Katsiadaki et al. 2006; Sebire et al. 2008). It disrupted not only spiggin (androgen 
specific expressed protein) production in the kidney in male three-spined stickleback, 
but also androgen-dependent sexual behavior such as nest building and courtship 
behavior (Sebire et al. 2008). However, other in vivo studies with rats on fenitrothion 
have been inconclusive about its anti-androgenic activity (Sohoni et al. 2001; Sunami 
et al. 2000). Fenitrothion is, as all the other organophosphate compounds, also an 
acetylcholinesterase inhibitor, and therefore a neurotoxic compound.  
2.2 Mixture effects of antiandrogens 
Even though it is common sense that biological systems exposed to a mixture of 
hundreds or thousands of chemicals, studies on mixture effects of EDCs is relatively 
delayed compared to mounting reports on individual chemical effects. It is mainly 
because mixture studies are considered to be challenging, both conceptually and 
experimentally. In spite of the difficulties, studies on combination effects of endocrine 
disrupting chemicals, especially androgen disrupting chemicals, have been conducted 
(Birkhoj et al. 2004; Christiansen et al. 2008; Gray et al. 2006; Hass et al. 2007; 
Hotchkiss et al. 2004; Jarfelt et al. 2005; Metzdorff et al. 2007; Nellemann et al. 2003; 
Rider et al. 2008).  
Mixture effects of chemicals are termed additive, antagonistic, or synergistic 
indicating whether the individual chemicals in the mixture act together to produce 
equal, diminishing or enhancing effects compared to the reference effects predicted 
on the basis of information about all components in the mixture. It is therefore 
important to choose the correct model to predict the anticipated reference effect. 
Additivity is usually assumed in mixture studies, and two concepts are available to 
describe the action of chemical mixtures depending on the presumed modes of action 
of the mixture components: dose addition and independent action (also called 
“response addition”). Dose addition applies to mixtures of chemicals that act through 
similar mode of action, and therefore based on this assumption, one chemical in the 
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mixture can be replaced by a fraction of another chemical at equieffective 
concentration without diminishing the overall combined effects. The toxic equivalency 
factor (TEF) approach is a widely used application of dose addition. Independent 
action is used for combinations of chemicals with distinct modes of action, and every 
component in the mixture provokes effects independent of all the other agents. 
Recently, to address the cumulative toxicity of complex mixtures containing 
chemicals with both same and different mechanisms, an integrate addition concept 
has been introduced, and it integrates dose addition and response addition into a 
single model (Rider et al. 2008).  
The choice of additivity model has significant implications in risk assessment (Rider 
et al. 2008). It is obviously impossible to test all the combination of chemicals in the 
environment, therefore prediction of mixture effects is important to assess the 
potential risk before regulations are made. Often human exposure levels of single 
chemicals are lower than the toxicity testing concentrations because of low resolving 
power of the most of in vivo and many in vitro assays. When predicting combination 
effects of mixtures with each component presenting at a dose level below or at the 
dose that produce no effect, response addition does not predict adverse effect, while 
dose addition does. Therefore, according to the dose addition concept we risk a higher 
exposure to chemicals that can cause cumulative adverse effects even if each single 
chemical does not if the regulations are made on chemical-chemical basis.  
Mixture studies of antiandrogenic chemicals provide more evidence supporting the 
dose addition concept than for response addition concept, regardless that the 
components have the same or different target in their mode of action. Nellemann et al. 
(2003) mixed vinclozolin and procymidone, both of which antagonize androgen 
receptor, and observed additivity in vivo as well as in vitro by comparing the observed 
effects with predicted effects by using an isobole method. Using the same method, 
Birkhøj et al. (2004) observed additive antiandrogenic effects in vitro of five 
commonly used pesticides acting dissimilarly. Metzdorff et al. (2007) studied the 
dysgenesis, changes of genitals and perturbation of gene expression in male rats after 
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in utero exposure to a mixture of three androgen receptor antagonists each at 
concentration where no effect were observed for individual compounds. The three 
chemicals were vinclozolin, flutamide and procymidone, which share a common 
antiandrogenic mechanism by antagonizing the androgen receptor, and the joint 
effects were dose additive with all measured endpoints (Metzdorff et al. 2007). The 
effects on sexual differentiation in rat were studied by Hass et al. (2007) with the 
same combination of chemicals, and once again, the effects of the mixture of similar 
acting antiandrogens were accurately predicted by the dose addition concept. In a 
more complicated experimental setup, mixture effects of seven antiandrogens that 
alter androgen signaling pathway via diverse mechanisms were studied in vivo (Rider 
et al. 2008). By comparing the predicted responses generated by models of dose 
addition, response addition or integrated addition, Rider et al. (2008) concluded that 
response addition and integrated addition underestimated mixture effects, and that 
chemicals that disrupt fetal tissue development during sexual differentiation act in a 
cumulative, dose-additive manner irrespective of the specific cellular mechanism of 
toxicity. Almost all the above studies claimed to get “something from nothing” results 
concerning the joint antiandrogenic effects.  
2.3 Zebrafish in endocrine disrupting chemical evaluation 
Wildlife populations are likely to be exposed to contaminants such as insecticides, 
pesticides and fungicides, because these chemicals usually end up in the aquatic 
ecosystems by surface water flow over fields or through the waste water from sewage 
plants.  
A series of international test guidelines for detecting EDCs in human and various 
animal species has been developed in numerous laboratories organized by the 
Organization for Economic Co-operation and Development (OECD). Among these 
medaka, fathead minnow, three-spined stickleback and zebrafish have been 
recommended as test species in the Fish Sexual Development Test (FSDT) aiming at 
detecting endocrine disrupting chemicals affecting fish. The FSDT measures the 
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change in the yolk protein (vitellogenin) concentration and sex ratio as the main 
endpoints. The principle of the proposed test method is based on the existing 
international guideline OECD TG 210 “Fish Early Life Stage Toxicity Test”, where 
exposure starts with fertilized eggs and in the FSDT test continues until sexual 
differentiation is finished.  
However, compared to the abundant studies of antiandrogens in the other fish species, 
investigations in zebrafish are relatively sparse. In the present project, the recently 
characterized zebrafish androgen receptor was used to test antiandrogens by 
investigating the subcellular localizations of the protein in the presence of four known 
antiandrogens. As previously mentioned, antiandrogens can potentially target any step 
in the androgen signaling pathway, however, this project mainly focuses on their 
influence on the nuclear transportation of AR in response to an androgen. Previous 
studies have shown varying results depending on the investigated antiandrogens. 
Human AR bound vinclozolin and p, p’-DDE and translocated to the nucleus, but 
failed to form nuclear foci, while BPA failed to induce the nuclear transportation of 
hAR (Lee et al. 2003; Roy et al. 2001; Tomura et al. 2001). In addition, studies 
investigating androgen receptor nuclear transportation with antiandrogens are 
relatively rare compared to those with pharmaceutical antiandrogens such as casodex 
and flutamide. This lack of knowledge and inconsistency in previously obtained 
results has made it difficult to form a general hypothesis. However, the following 
hypothesis is made: the presence of a single antiandrogen induces nuclear 
translocation of zfAR, but fails to induce the formation of nuclear foci; while when 
the antiandrogen is present together with 11-ketotestosterone, nuclear foci formation 
is inhibited in a dose-response manner. Another aim of this project is to investigate 
the mixture effects of the four antiandrogens in the presence 11-ketotestosterone. A 
dose-addition response is expected because of previous compelling evidence.  
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Materials and methods 
Construction of expression vector 
Expression plasmid pEYFP-zfAR was constructed by Anne Jørgensen (unpublished). 
To help the reader of this thesis, the construction of the expression plasmid is 
described briefly. Total cDNA was prepared from zebrafish tissue (Jorgensen et al. 
2007). To construct the expression vector that express YFP-zfAR fusion protein, full 
length zfar was first amplified by PCR from the total cDNA preparation. At the same 
time, BamHI sites were induced flanking the PCR fragment by primers listed in Table 
1. PCR was performed according to the protocol for Expand Long Template PCR 
system (Roche). Amplification conditions were: 94°C for 30 s (94°C for 15 s, 65°C 
for 30 s, and 72°C for 4 min) for 40 cycles followed by a 7 min extension period at 
72°C. PCR product was gel purified using the High Pure PCR Product Purification 
Kit (Roche). The AR PCR product and the pEYFP-C1 vector were digested with 
BamHI, according to manufacturer’s instructions (Fermentas). pEYFP-C1 vector was 
de-phosphorylated using Shrimp Alkaline Phosphatase (SAP) according to 
manufacturers instructions (USB Corporation). Inserts and pEYFP-C1 vector were 
ethanol precipitated and the AR gene was ligated into pEYFP-C1 with T4 ligase 
(Invitrogen) and were fully sequenced. The resulting fusion protein has YFP at the N 
terminus, which allows convenient visualization by fluorescence microscopy.  
Table 1 Oligonucleotide primers used for cloning the Danio rerio androgen receptor into 
pEYFP-C1 expression vector. 
Primer Amplicon Sense primer 5´-3´ Antisense primer 5´-3´ 
EYFP-AR 2607 nt ggatccatggaggttcgggtcggg ggatcctcatttgtggaacaggattgg 
 Restriction sites are underlined. 
Mutagenesis 
Five zfAR mutants (Table 2) were generated using pEYFP-zfAR expression vector as 
template. Mutagenesis was performed using site-directed mutagenesis with pfuultra 
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high fidelity DNA polymerase (Stratagene). Primers (Table 2) were designed by The 
QuikChange® Primer Design Program on Stratagene’s website 
(http://www.stratagene.com/tradeshows/feature.aspx?fpId=118). Standard PCR 
conditions were 1 cycle of 95oC 2 min; 30 cycles of 95oC 30 sec, 65oC 30 sec, 72oC 6 
min; and ended with 72oC 7 min. Mutant pEYFP-zfARR582K583L584R585K586A was 
generated with a slightly different PCR condition with 1 cycle of 95oC 2 min; 30 
cycles of 95oC 30 sec, 70oC 30 sec, 72oC 6 min, and ended with 72oC 7 min. The 
PCR products were digested with DpnI for 1 hour and then transformed into Top 10 
competent cells by electroporation and selected on kanamycin containing LB plates. 
All zfAR mutants were confirmed by fully sequencing.  
Table 2 Plasmids and primers in site-directed mutagenesis 
Plasmids Primers Primer Sequence 
Armut1_S 
5'-aactgcccatcctgccgtctgggggcgtgttttga
ggttggaatgac-3' 
pEYFP-zfARK570G,K571A 
Armut1_AS 
5'-gtcattccaacctcaaaacacgcccccagacggca
ggatgggcagtt-3' 
Armut2_S 
5'-ggttggaatgaccctgggagccattggacagatga
aaggtcc -3' 
pEYFP-zfARdel582-586 
Armut2_AS 
5'-ggacctttcatctgtccaatggctcccagggtcat
tccaacc -3' 
Armut3_S 
5'-ttttgaggttggaatgaccctgggagccgccgcgg
cggcggcgattggacagatgaaaggtccggatgag-3' 
pEYFP-zfARR582K583L584R585K586A 
Armut3_AS 
5'-ctcatccggacctttcatctgtccaatcgccgccg
ccgcggcggctcccagggtcattccaacctcaaaa-3' 
Armut4_S 
5'-ccctgggagcccgcatgctgatgatgattggacag
atgaa-3' 
pEYFP-zfAR K583R585K586M
 
Armut4_AS 
5'-ttcatctgtccaatcatcatcagcatgcgggctcc
caggg-3' 
pEYFP-zfARK570G,K571A,del582-586*   
* Plasmid pEYFP-ARK570G,K571A,del582-586 is a double mutant and it was constructed through two 
steps: plasmid pEYFP-ARK570G,K571A was first constructed using primers Armut1_S and 
Armut1_AS, and then it was used as template and further mutation was induced using primer 
Armut2_S and Armut2_AS.  
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Cell culture 
ZfAR subcellular distribution was investigated in Hela cells and ZFL cells. Hela cells 
were grown in DMEM supplemented with 5% FBS and 0.1% penicillin/ streptomycin 
at 37oC, with 5% CO2 in 75 cm
2 cell culture flasks. Cells were subcultured every 3-5 
days. For this purpose, they were first rinsed with 5ml PBS (Gibco) and then detached 
with 1ml of trypsin for 3-5 min at 37oC. Detachment was observed under a 
microscopy. Trypsination was stopped by addition of 5ml of 5% FBS containing 
medium. Cells were then split into two new 75 cm2 cell culture flasks. 
Zebrafish liver cells ZFL (ATCC CRL- 2643) were grown in 50% Leibovitz’s L-15 
medium with 2mM L-glutamine (Gibco 11415), 35% Dulbecco’s modified Eagle’s 
medium with 4.5 g/l glucose and 4mM L-glutamine (Gibco 52100), 15% Ham’s F12 
with 1mM L-glutamine (Gibco 21700), (all without sodium bicarbonate), and 
supplemented with 0.15 g/l sodium bicarbonate, 15mM HEPES, 0.01 mg/ml insulin 
(Sigma I-1882), 50ng/ml EGF (unfiltered, Sigma), and 5% heat-inactivated fetal 
bovine serum. Growth media were freshly mixed every time before use. To prepare 
the medium, DMEM and Hams’ F12 were first dissolved in 0.8-0.9x volume of 
distilled water. The pH of the medium was adjusted to 7.4 with 5 M NaOH, and water 
was added to achieve the final (1×) volume. Then the medium was filtered through 
0.2-µm filters. Insulin stock solution (10 mg/ml) was prepared in acidified water (100 
µl of glacial acetic acid in 10 ml of sterile water). Cells were grown at 28oC, with 
100% air in 75 cm2 cell culture flasks. Cells were subcultured every 5-7 days. For this 
purpose, they were first rinsed with 5ml PBS (Gibco) and then detached with 1ml of 
trypsin for 5-8 min at room temperature. Detachment was observed under a 
microscopy. Trypsination was stopped by addition of 5 ml of 10% FBS containing 
medium. Cells were centrifuged for 10 min at 200 g. Cell pellets were resuspended in 
serum-free medium and split into two new 75 cm2 cell culture flasks containing 
serum-free medium. Cells were allowed to settle and attach to the bottom by 
incubating at 28oC for 30 min, and then 5% FBS was added.  
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Transfection and microscopy 
2x105 cells per well were seeded in a 24-wells plate 24h before transfection. At 
90-95% confluence, the cells were transfected with 0.8µg DNA/well. Transient 
transfections of Hela cells and ZFL cells with pEYFP-zfAR and its mutant derivatives 
were performed with Lipofactamine 2000 (Life Technologies Inc., USA) according to 
manufacture’s recommendation. For the purpose of observing nuclear translocation of 
zfAR induced by 11-KT and the effects of antiandrogens, the natural ligand 11-KT 
and/or test chemicals were added at the time of transfection, and fluorescence was 
observed with a Leica DMIRB fluorescence microscope after 24 hours and/or 48 
hours. The cells were classified into five categories according to a scoring system 
widely used to examine subcellular localization of steroid receptors (Jenster et al. 
1993; Poukka et al. 2000; Sackey et al. 1996): N, dominantly nuclear fluorescence; 
N>C, nuclear fluorescence exceeding cytoplasmic fluorescence; N=C, equal nuclear 
and cytoplasmic fluorescence; N<C, cytoplasmic fluorescence exceeding nuclear 
fluorescence; C, exclusive cytoplasmic fluorescence (representative cells for each 
category are shown in figure 2). In this project, the categories were assigned numbers 
representing the percent of fluorescence in the nucleus: N, 95%; N>C, 75%; N=C, 
50%; N<C, 25%; C, 0%, meaning if a cell has been rated as N, then this cell counts in 
the calculation of nuclear translocation percentage (see below) as 95%, if as N>C, it 
counts as 75% nuclear fluorescence, and so on. For each sample, 100-200 positive 
cells were rated. The percentage of cells that fall in each category was noted as N%, 
(N>C)%, etc. To get an overall view of how much protein was in the nucleus, the 
following way was used to calculate the “nuclear translocation percentage”: nuclear 
translocation percentage = N% x 95%+ (N>C)% x 75% + (N=C)% x 50% +(N<C)% 
x 25% + C% x 0%. 
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Figure 2. According to the localization of fluorescence, cells were classified into five 
categories according to a scoring system widely used to examine subcellular localization 
of steroid receptors (Jenster et al. 1993; Poukka et al. 2000; Sackey et al. 1996): N, 
dominantly nuclear fluorescence; N>C, nuclear fluorescence exceeding cytoplasmic 
fluorescence; N=C, equal nuclear and cytoplasmic fluorescence; N<C, cytoplasmic 
fluorescence exceeding nuclear fluorescence; C, exclusive cytoplasmic fluorescence 
Representative pictures from experiments were shown. 
Chemicals 
The natural androgen 11-ketotestosterone (cat. No: K8250) and the test chemicals 
bisphenol A (cat. No: 239658), p,p’-DDE (cat. No: PS696), vinclozolin (cat. No: 
45705) and fenitrothion (cat. No: 442592) were all purchased from Sigma-Aldrich. 
Since all test compounds are hydrophobic substance, each compound was dissolved 
in DMSO so that all stock solutions were 1000 times concentrated compared to the 
final test concentrations and the final concentration of DMSO in cell culture medium 
does not exceed 0.1%. For all experiments that need mixture of chemicals, master 
mixtures of chemicals were made so that each ingredient was 1000 times 
concentrated compared to the test concentration. 
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Cytotoxicity assessment 
MTT assay for quantifications of Hela cells and ZFL cells was established as follows: 
1,250, 2,500, 5,000, 7,500, and 10.000 cells/well for Hela cells and for ZFL cells, 
7,500, 10,000, 25,000, 75,000 and 100,000 cells/well were plated in 96 well plate in 
200 µl phenol red free growth medium (or normal growth medium for ZFL cells) and 
allowed to settle. Three replicates were setup for each cell density. At the same time, 
wells containing only medium without cells were prepared and used later for 
background correction. After 24 h incubation the medium was removed by gentle 
aspiration. 100 µl phenol red free DMEM plus 10 µl 12 mM MTT stock solution were 
premixed and immediately added into each well. After incubation with MTT for 4h at 
37℃, 90µl medium was removed and 50µl of DMSO was added into each well to 
dissolve formazan. The plate was incubated at 37 ℃ (or 28 ℃ in the case of ZFL cells) 
for 15 min before absorbance at 540 nm was measured by a Bio-Tex Synergy 
microplate reader. Absorbance in wells with cells was corrected by subtracting the 
medium blank.  
The procedures of MTT assays used for cytotoxicity tests were based on the above 
protocol. 7,500 cells/well (or 50,000cells/well) of Hela cells (or ZFL cells) were 
plated in 96 well plate. Also, wells with 0.1% DMSO were set up to test the solvent 
cytotoxicity, and wells with only cells and medium were set up as control. Cells were 
exposed to test chemicals for 24 hours before MTT was added. After corrected 
absorbance in wells with cells by subtracting the medium blank, the toxicity of the 
compound was calculated as absorbance with test compounds / absorbance without 
compound *100%. 
Studies of antiandrogenic chemicals 
The subcellular localization of zebrafish androgen receptor in the presence of the 
antiandrogenic chemicals bisphenol A, p-p’-DDE, vinclozolin, and fenitrothion was 
studied by observing the localization of fluorescence in Hela cells transfected with 
pEYFP-zfAR as described previously. The nuclear translocation percentages were 
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calculated and used for comparison between each sample. In all experiments, a 
solvent control with 0.1% DMSO was always included and used as background 
translocation. Each experiment was repeated at least once.  
The nuclear translocation of zfAR in Hela cells was first studied in the presence of 
each chemical at concentrations of 10-9M, 10-8M, 10-7M, 10-6M, and 10-5M without 
11-ketotestosterone. Then the subcellular locations of zfAR were investigated in the 
presence of both 6 nM 11-ketotestosterone and one anti-androgenic chemical. Tested 
concentrations for each compound were 10-9M, 10-8M, 10-7M, 5x10-7M, 10-6M, 
5x10-6M, and 10-5M. Meanwhile, one sample with only 6 nM 11-KT was setup as a 
positive control. Dose-response curves were generated for each test chemical and 
used for evaluating the potency of each chemical. Nuclear translocation percentages 
for samples that had been treated with both 6 nM 11-KT and antiandrogen were 
compared with the control (only 6nM 11-KT), and the lowest concentrations which 
caused statistically significant difference (student’s t-test two-tailed, P=0.05) were 
called the Lowest Observed Effect concentration (LOEC), and the concentration 
below the LOEC are called No Observed Effect Concentration (NOEC).  
To study the mixture effects of these four environmental chemicals, two master 
mixtures with a ratio of 2:2:1:1 of BPA: p, p’-DDE: vinclozolin: fenitrothion were 
made. The concentration of each ingredient in both mixtures was 1000 times higher 
than the tested concentration, so that the final test concentration for mixture 1 (Mix1) 
would be 5x10-7M BPA, 5x10-7M p,p’DDE, 10-7M vinclozolin, 10-7M fenitrothion, 
and 6nM 11-KT, and for mixture 2 (Mix 2) would be 10-6M BPA, 10-6M p,p’DDE, 
5x10-7M vinclozolin, and 5x10-7M fenitrothion and 6nM 11-KT. Meanwhile, one 
sample with only 6 nM 11-KT was setup as a positive control. The inhibition of 
nuclear translocation induced by 11-KT was calculated as: Inhibition percent = 
(nuclear translocation percentage with 6 nM-KT – nuclear translocation percentage 
with both 6nM 11-KT and the antiandrogenic chemical)/ nuclear translocation 
percentage with 6nM 11-KT x 100%.  
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Results 
Construction of Expression Vector pEYFP-zfAR 
In order to study the subcellular location of zfAR, a fusion protein with yellow 
fluorescence protein (YFP) and zfAR was constructed. This construction was fully 
sequenced, and the resulting protein sequence of zfAR was aligned with the protein 
sequence from NCBI (NP_001076592) by the AlignX function in Vector NTI 
Advance 10 software (Invitrogen). Three amino acids were found to be different 
(figure 3): P4R, G54D, and D682G (amino acids written in front of numbers are from 
NP_001076592, numbers correspond to the position of the amino acid, amino acids 
written after numbers are from pEYFP-zfAR). 
 
Figure 3. Alignment analyses between protein sequence of zfAR in the fusion protein 
expressing vector pEYFP-zfAR and the protein sequence from NCBI (NP_001076592) by 
Vector NTI Advance 10 (Invitrogen). Differences between the two protein sequence are 
circled.  
In order to determine the degree of conservation of the three amino acids, a second 
alignment was conducted with androgen receptors from Atlantic croaker, Japanese 
medaka, Gold fish, Japanese eel and Rainbow trout. In figure 4, P4R and G54D from 
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zfAR seems to locate in a hypervariable region of the protein, while the aspartic acid 
in D682G locates in a highly conserved region and is itself conserved among all 
compared species (figure 4). This high conservation might indicate a functional 
importance of this aspartic acid. Therefore, the G682 in pEYFP-zfAR was changed 
into an aspartic acid (D) by site-directed mutagenesis. The resulting plasmid is used in 
all the experiments in this project. 
ZfAR Subcellular Localization 
In order to study the subcellular location of zfAR with and without the presence of the 
natural ligand 11-KT, the fusion protein YFP-zfAR was expressed in human cervical 
cancer cell line Hela and zebrafish liver cell line ZFL.  
First, subcellular localizations of YFP and YFP-zfAR with/without the presence of 
androgen were studied in Hela cells. YFP showed even distribution between 
cytoplasmic and nuclear compartments regardless of the addition of androgen (figure 
5). In contrast, YFP-zfAR chimeras located mostly in cytoplasm in some cells or 
evenly in cytoplasm and nuclei in other cells without the adding of ligand, and 
exposure to both 10nM dihydrotestosterone (DHT) and 10nM 11-ketotestosterone 
(11-KT) resulted in efficient transfer of YFP-zfAR from cytoplasm into nuclei (figure 
5). Through this pilot experiment, cell specific distribution of YFP-zfAR was 
observed, therefore a systematic approach was used in following experiments in 
which at least 100 cells were analyzed. Further, because the androgen receptor 
investigated in this project is from zebrafish, I would have preferred to analyze the 
subcellular location of the protein in the zebrafish cell line ZFL. However, due to low 
transfection efficiency in these cells, a systematic investigation was not performed, 
while the high transfection efficiency of Hela cells permitted the analyses. 11-KT was 
used as the test androgen because 11-KT is the major natural androgen in fish. 
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Figure 4. Alignment analyses of androgen receptors from zebrafish, Atlantic croaker, 
Japanese medaka, Gold fish, Japanese eel and Rainbow trout by Vector NTI Advance 
10 (Invitrogen). P4R, G54D, and D682G in zebrafish AR (amino acids written in front of 
numbers are from NP_001076592, numbers stand for the position of the amino acid, 
amino acids written after numbers are from pEYFP-zfAR.) are circled. D682G is 
conserved among all compared species 
 40
 
 
Figure 5. Subcellular localization of YFP and YFP-zfAR in Hela cells in response to 
androgens. A-B: Hela cells expressing YFP. A: no ligand added; B: 10 nM 11-KT added. C-D: 
Hela cells expressing YFP-zfAR. C: no ligand added; D: 10nM dihydrotestosterone (DHT) 
added; E: 10nM of 11-ketotestosterone (11-KT) added.  
 
In the systematic analysis of translocation, the localization of the YFP-zfAR chimeras 
in Hela cells were classified into five categories (see figure 2 in material and methods) 
and an index called nuclear translocation percentage was introduced to indicate the 
overall percentage of protein in nucleus (see material and methods). In the absence of 
11-KT, zfAR distributed evenly between cytoplasm and nucleus (N=C) in almost 60% 
of the observed Hela cells, and in around 20% of the cells more cytoplasmic than 
nuclear (N<C) fluorescence was observed (figure 6). The overall nuclear translocation 
percent was 47.04% (table 3). Exposure to 1nM 11-KT resulted in a transfer of 
72.68% of zfAR from cytoplasm into nucleus (table 3). Around 65% of the cells 
transfected with zfAR showed nuclear exceeding cytoplasm (N>C) or exclusively 
nuclear (N) fluorescence, and around 33% of the cells showed an even distribution 
between nucleus and cytoplasm (figure 6). As the concentration of 11-KT increased to 
10nM, a more complete transfer of zfAR into nucleus was observed. 90% of the cells 
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showed predominantly nuclear (N) or nuclear exceeding cytoplasmic (N>C) 
fluorescence (figure 6), which results in an overall nuclear translocation of zfAR to 
90.03% (table 3).  
 
 
Figure 6. Nuclear translocation of YFP-zfAR in response to 11-KT. Hela cells were transfected 
with plasmid pEYFP-AR At the time of transfection, 1nM or 10nM of the natural ligand 
11-ketotestosterone was added. At 24 hours after transfection, localization of fluorescence was 
analyzed. For each sample, 100-200 cells were observed and placed in to five categories: N, 
exclusively nuclear fluorescence; N>C, nuclear fluorescence exceeding cytoplasmic 
fluorescence; N=C, equal nuclear and cytoplasmic fluorescence; N<C, cytoplasmic 
fluorescence exceeding nuclear fluorescence; C, exclusively cytoplasmic fluorescence. Each 
experiment was repeated twice. Representative pictures taken for samples without addition of 
ligand, with 1 nM 11-ketotestosterone and with 10 nM 11-ketotestosterone are shown. 
 
 
The higher nuclear translocation percentage induced by 10nM 11-KT compared to 
1nM 11-KT indicated a concentration-dependent transfer of zfAR from cytoplasm 
into nucleus. Therefore a dose-response study was performed to investigate the 
relationship between the concentration of the androgen and the import of zfAR. 
Furthermore, in order to establish whether the nuclear translocation is cell cycle 
dependent, 48 hour samples were also analyzed in the study. A clear dose-response 
fashion was observed for the 11-KT induced nuclear translocation of zfAR both at 24 
and 48 hours after transfection (figure 7). The curves derived from the two time 
points do not deviate, and therefore in all the following experiments localization of 
zfAR was only analyzed at 24 hours.  
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Figure 7. Dose-response curves for zfAR nuclear translocation induced by 
11-ketotestosterone at 24 hours and 48 hours after addition of ligand. The curves from the two 
time points do not deviate from each other (Two-sample Kolmogorov-smirnov test, P>0.1). 
 
In summary, zfAR was imported to nucleus from cytoplasm in response to addition of 
11-KT and DHT. This androgen regulated distribution of zfAR in the cells showed a 
dose-response relationship that did not change when measured at 24 hours and 48 
hours.  
 
Bioinformatics search for Nuclear Localization Sequence (NLS) within zfAR 
The androgen-dependent nuclear translocation of zfAR led to a search for a nuclear 
localization sequence (NLS) within zfAR. To determine the NLS, the amino acid 
sequence of zfAR was aligned with the human androgen receptor (hAR) amino acid 
sequence using ClustalW. The NLS sequence in hAR has previously been identified 
(Zhou et al. 1994). 
Nuclear localisation sequence 
Homo sapiens AR (604-620)     RKCYEAGMTLGARKLKK 
Danio rerio AR (570-586)      KKCFEVGMTLGARKLRK 
                                   :**:*.*********:*  
*: identical residues between the ARs, : highly conserved residues, . semi-conserved amino 
acids. 
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A bipartite type of NLS (KKCFEVGMTLGARKLRK ) ranging from 570 aa to 586 
aa overlapping the DNA binding domain and the hinge region was predicted in zfAR. 
The first two basic amino acid (Lys-Lys) and the last five basic amino acids 
(Arg-Lys-Leu-Arg-Lys) separated by 10 amino acids make up the most characteristic 
feature of a bipartite type nuclear localization sequence. 
Mutagenesis and the subcellular localization of the zfAR mutants 
To determine if the predicted NLS is sufficient for nuclear import of zfAR, 
site-directed mutagenesis was conducted to substitute specific amino acids in the 
sequence. Five mutants were made targeting the first two amino acids and the last five 
amino acids of the predicted NLS (KK…RKLRK ) (figure 8). All five plasmids 
containing the mutated YFP-zfAR gene were transfected into Hela cells and ZFL cells, 
and the subcellular localization of the fusion proteins were observed with and without 
11-KT.  
 
Figure 8. Mutagenesis targeting of the bipartite NLS predicted in zebrafish androgen receptor 
and the structure of relevant amino acids. Changed or deleted amino acids are underlined or 
are shown as”-“. DBD: DNA Binding Domain. LBD: Ligand Binding Domain 
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In mutant 1 (zfARK570G, K571A) the first two basic lysines were substituted with 
two small neutral amino acids (glycine and alanine) in order to determine the 
significance of the charge of the two lysines. In the absence of 11-KT, 8.60% of the 
mutated chimeras were located in nuclei and the representative distribution observed 
in almost 80% of the cells was predominantly cytoplasmic (C) (figure 9 and table 3). 
Exposure to 1nM and 10nM 11-KT resulted in increasing nuclear translocation 
percentage to 28.69% and 48.35%, respectively (table 3). This indicates a 
concentration-dependent partial nuclear transport of the mutated protein, and probably 
a second nuclear import signal. Mutant 2 (zfARdel582-586) was designed to 
investigate the significance of the second cluster of basic amino acids. Nuclear import 
of mutant 2 was very low compared to that of the wild type protein (figure 9), even 
though slight increases of nuclear translocation percentage to 25.58% and 27.98% 
were observed when 1nM and 10nM 11-KT was added respectively (table 3). In 
contrast to the first mutant whose nuclear translocation percentage increased almost 
20% as the ligand concentration increased from 1nM to 10nM, the nuclear 
translocation percentage for mutant 2 only increased 2%, indicating a disturbed ligand 
binding function that probably resulted from the conformational change caused by the 
deletion. To minimize the possible destruction of protein folding caused by the 
deletion, mutant 3 (zfARR582K583L584R585K586A) was constructed, in which the 
introduced five alanines differ from the original amino acids both in size and charge. 
In addition, in order to eliminate the size difference, methionine was used in mutant 4 
(zfARK583R585K586M). Compared to the first two mutants, less nuclear 
translocation was observed for both mutant 3 and 4 when 1nM 11-KT was present 
(figure 9 and table 3), and 12% and 13% increase in nuclear translocation percentage 
were observed when the ligand concentration increased to 10nM for mutant 3 and 4 
respectively. The last mutant 5 (zfARK570G, K571A, del582-586) is a double mutant 
with changes in both clusters of basic amino acid in the predicted NLS. Nuclear 
import of the mutant was severely disrupted (figure 9), but a nuclear translocation of 
23.39% was still observed when 10nM 11-KT was added (table 3).  
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Another observation with the mutated zfAR is the formation of fluorescence foci 
(figure 9), indicating receptor cluster, in the presence of 10nM 11-KT, especially in 
cells transfected with mutant 1 (zfARK570G, K571A) and mutant 5 (zfARK570G, 
K571A, del582-586). Receptor clusters were not observed in cells transfected with the 
wild type zfAR regardless of the presence of 11-KT or in cell transfected with 
mutated zfAR without the addition of 11-KT.  
 
 Table 3. Nuclear translocation of zfAR wild type and its mutants 
 ARwt Mutant 1 Mutant 2 Mutant 3 Mutant 4 Mutant 5 
Without ligand 
47.04% 
±8.25% 
8.60% 
±4.64% 
10.52% 
±0.70% 
7.18% 
±1.69% 
4.71% 
±0.05% 
6..90% 
±1.89% 
       
1nM 11-KT 
72.68% 
±4.35% 
28.69% 
±7.50% 
25.58% 
±5.90% 
11.32% 
±4.34% 
6..57% 
±1.54% 
8..97% 
±2.03% 
       
10nM 11-KT 
90.03% 
±2.27% 
48.35% 
±8.07% 
27.98% 
±3.92% 
23.62% 
±6.98% 
19.98% 
±2.70% 
23.39% 
±1.93% 
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Figure 9. Mutagenesis of the bipartite NLS interfere with nuclear translocation of YFP-zfAR. 
Hela cells were transfected with plasmid pEYFP-AR or the mutants: pEYFP-ARK570G,K571A,, 
pEYFP-ARdel582-586,pEYFP-ARR582K583L584R585K586A,pEYFP-ARK583R585K586M, pEYFP-ARK570G,K571A,
del582-586. At the time of transfection, 1nM or 10nM of the natural ligand 11-ketotestosterone was 
added. At 24 hours after transfection, localization of fluorescence was analyzed. For each 
sample, 100-200 cells were observed and placed in to five categories: N, exclusively nuclear
fluorescence; N>C, nuclear fluorescence exceeding cytoplasmic fluorescence; N=C, equal 
nuclear and cytoplasmic fluorescence; N<C, cytoplasmic fluorescence exceeding nuclear 
fluorescence; C, exclusively cytoplasmic fluorescence. Each experiment was repeated twice. 
Representative pictures taken for samples without adding ligand, with 1nM
11-ketotestosterone and 10nM 11-ketotestosterone are shown. 
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Preliminary investigations of the subcellular distribution of zfAR and its five mutants 
were performed with ZFL cells. By observing individual ZFL cells instead of at least 
100 cells in the case of Hela cells, a subjective impression was that the location of 
zfAR in the zebrafish cell line is quite similar to that in Hela cells, and that the 
mutations in NLS destroyed the nuclear translocation of zfAR (figure 10). Picture for 
the double mutant 5 (zfARK570G, K571A, del582-586) is not shown due to low 
picture quality. 
 
Figure 10. Mutagenesis of the bipartite NLS interfere with nuclear translocation of YFP-zfAR in 
ZFL cells. ZFL cells were transfected with plasmid pEYFP-AR or its mutant derivatives: 
pEYFP-ARK570G,K571A,,pEYFP-ARdel582-586,pEYFP-ARR582K583L584R585K586A,pEYFP-ARK583R585K586M.  
At the time of transfection, 1nM or 10nM of the natural ligand 11-ketotestosterone was added. 
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In summary, mutations in NLS, either in the first or the second cluster of the basic 
amino acid, severely damaged the 11-KT dependent nuclear translocation of zfAR. A 
higher nuclear translocation of YFP-zfARK570G, K571A was observed upon exposure to 
10nM 11-KT compared to the other mutants. 
Quantification of Hela cells and ZFL cells and cytotoxicity test using MTT assay 
Before studying the effects of BPA, p, p’-DDE, vinclozolin and fenitrothion on the 
subcellular localization of zfAR, it is necessary to investigate the possible toxicity 
they may have in Hela cells and ZFL cells. For this purpose, the MTT assay was 
chosen. The principle of this assay is based on 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide(MTT) reduction and it is widely used for quantitatively 
assessing cell viability and proliferation. It is generally believed that MTT reduction 
into formazan is dependent on cellular redox activity in living cells, and is therefore 
an indicator for mitochondrial function. MTT itself is a pale yellow tetrazolium salt 
which can be reduced by the mitochondrial dehydrogenase enzyme from viable cells 
to a dark blue formazan crystal. Formazan is impermeable to cell membranes and thus 
accumulate within healthy cells. Addition of a detergent results in solubilisation of the 
cells and release of the crystals which are soluble. The number of surviving cells is 
directly proportional to the level of the formazan product created. The color can then 
be quantified using a colorimetric assay. 
To establish this assay with Hela cells and ZFL cells, the first step was to study 
influencing parameters, such as cell density. Since ZFL cells need to be grown at 
28℃, MTT incubation was conducted at 28℃ instead of 37℃ as suggested by the 
manufacturer. A linear relationship between cell number and absorption was 
established for up to 10,000 cells/well (R=0.957) for Hela cells (figure 11a) and 
100,000 cells/well (R=0.943) for ZFL cells (figure 11b). Since cell density of 7,500 
cells/well for Hela cells and 50,000 cells/well for ZFL cells resulted in reasonably 
strong signals, those seeding densities were used for further investigation of toxicity 
of the four anti-androgens in Hela cells and ZFL cells. 
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Figure 11. Quantitation of Hela cells (a) and ZFL (b) cells using MTT assay. Cells were 
incubated with MTT for 4h in a microplate. Absorbance measurements at 540 nm were made 
using a microplate reader. Each data point represents the mean value of samples in triplicate. 
 
No significant toxicity of the four antiandrogens was observed for Hela cells and ZFL 
cells from concentration 10-8M to 10-5M (figure 12). 
 
 
Figure 12. MTT assay for testing cytotoxicity in Hela cells (a) and ZFL cells (b) of BPA, 
p,p’-DDE, vinclozolin and fenitrothion at concentration 10-8M, 10-7M, 10-6M, and 10-5M. MTT 
assay were performed after cells had been exposed to chemical for 24 hours. Absorbance of 
samples treated with chemicals was compared with that of untreated samples. Inhibitions of 
absorbance were calculated. Each data point is average of 3 replicates.  
 
Subcellular localization of zfAR in the presence of androgen disruptors 
In order to establish whether the four tested antiandrogens, BPA, p, p’-DDE, 
vinclozolin and fenitrothion alone induce nuclear translocation of zfAR, Hela cells 
and ZFL cells were transiently transfected with pEYFP-zfAR, and the subcellular 
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fluorescence distributions were observed after treating cells with each antiandrogen 
over a concentration range from 10-9 to 10-5M. The distribution of zfAR in both Hela 
cells (figure 14 A-H) and ZFL cells (figure 14 a-c) did not deviate from the pattern 
observed when no ligand was added, except that in Hela cells 10-9M BPA induced 
nuclear translocation (almost 80%) (figure 13 and figure 14 A), but not at other higher 
tested concentrations (figure 13 and figure 14 E). 10-5M vinclozolin also slightly 
induced nuclear translocation of zfAR (figure 13 and figure 14 G), while 10-5M 
fenitrothion seemed to slightly reduce AR translocation into the nucleus compared to 
the control when no ligand was added (figure 13 and figure 14 H). 
 
 
 
 
Figure 13. Localization of zfAR in the presence of antiandrogens at concentration 10-9M, 
10-8M, 10-7M, 10-6M, and 10-5M in Hela cells. Concentration 0 represents the control sample 
without adding any ligand. BPA: bisphenol A; V: vinclozolin; F fenitrothion. Each data point is 
the average of 2 replicates. 
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Figure 14. Subcellular localization of YFP-zfAR in the presence of single antiandrogen in Hela 
cells and ZFL cells. At the time of transfection, BPA, p,p’-DDE, vinclozolin and fenitrothion 
were add into the media at concentration from 10-9M to 10-5M. Pictures were taken at 24 hours 
after transfection. A-D: Hela cells treated with 10-9M of BPA, p,p’-DDE, vinclozolin and 
fenitrothion; E-H: Hela cells treated with 10-5M of BPA, p,p’-DDE, vinclozolin and fenitrothion; 
a-c: ZFL cells treated with 10-5M of BPA, p,p’-DDE, and vinclozolin. Picture for ZFL cells 
treated with 10-5M fenitrothion is missing because of low picture quality. 
 
Subcellular localization of zfAR in the presence of antiandrogens and 11-KT 
Since the antiandrogens themselves did not result in nuclear import of the zfAR, it 
was interesting to investigate if the co-addition of antiandrogen would disrupt the 
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nuclear translocation of zfAR induced by 11-KT. 6nM of 11-KT was mixed with each 
individual antiandrogen over a concentration range from 10-9 to 10-5M, and added to 
Hela cells transiently transfected with the YFP-zfAR fusion protein. The subcellular 
fluorescence was then observed. While 6nM 11-KT alone induced around 85% of 
zfAR nuclear translocation as observed previously, even distribution of fluorescence 
between the nuclear and cytoplasmic compartment was observed in Hela cells treated 
with 6 nM 11-KT and one of the four antiandrogens at 5 µM, indicating the nuclear 
import of zfAR was destroyed by the adding of around 1000 fold of antiandrogen 
(figure 15). This inhibition of nuclear transport of zfAR by the antiandrogen showed a 
concentration-dependent manner (figure 16). In figure 16, the lowest concentration 
that cause observable effects (Lowest Observed Effect Concentrations (LOEC)) for 
bisphenol A and p, p’-DDE were 10-6M, with inhibition of nuclear translocation of 
14.31% and 14.48%, respectively (table 4 and 5) Vinclozolin and fenitrothion showed 
significant effect on nuclear translocation of zebrafish androgen receptor at 
concentration of 5x10-7M, with inhibition of 19.64% and 12.85% respectively (table 4 
and 5). By comparing the inhibition percentage, vinclozolin seems to be the most 
potent antiandrogen among the four (figure 16). As the concentration increase, all four 
chemicals reach their maximum effects at concentration of 5x10-6M. 
 53
 
Figure 15. 11-KT dependent nuclear translocation of zebrafish androgen receptor in Hela cells 
was disrupted by addition of antiandrogen (a) 6nM 11-KT together with 10-9M, 10-6M and 
5x10-6M bisphenol A (BPA); (b) 6nM 11-KT together with 10-9M, 10-6M and 5x10-6M p,p;-DDE; 
(c) 6nM 11-KT plus 10-9M, 5x10-7M and 5x10-6M vinclozolin (V); (d) 6nM 11-KT plus 10-9M, 
5x10-7M and 5x10-6M fenitrothion (F). Hela cells were transfected with plasmid pEYFP-AR. 
Androgen disrupting chemicals (concentration at 10-9M, 10-8M, 10-7 M, 5x10-7 M, 10-6 M, 5x10-6 
M, and 10-5 M) and 6nM 11-KT were added at the same time as transfection. After 18-24 hours, 
fluorescence was observed under a fluorescence microscope. Representative pictures from 
samples with androgen disrupting chemicals at the lowest concentration (10-9M), at the lowest 
concentrations that caused statistically significant difference (LOEC, P=0.05) and at the 
concentration that caused maximum effect (5x 10-6M) are shown. 
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Figure 16. 6nM 11-KT induced zfAR nuclear translocation is inhibited by single antiandrogen  
in a concentration dependent manner (tested concentrations were 10-9M, 10-8M, 10-7M, 
5x10-7M, 10-6M, 5x10-6M, and 10-5M) Concentration 0 represents the control with only 6nM 
11-KT. Nuclear translocation percentages for samples treated with antiandrogen were 
compared with the control. Each data point is average of 2-3 replicates.  
 
Mixture effects 
To test if the prevailing dose addition theory in predicting combinational effects of 
chemicals can be applied in our system, the nuclear translocation of zfAR in the 
presence of mixtures of BPA, p, p’-DDE, vinclozolin and fenitrothion with mixing 
ratio 2:2:1:1 was investigated in two concentrations together with 6nM 11-KT. The 
ratio and the concentration of the mixtures were designed based on single chemical 
effects from the previous experiments (figure 16). The first mixture (Mix 1) consists 
of 5x10-7M BPA, 5x10-7M p, p’-DDE, 10-7M vinclozolin, and 10-7M fenitrothion, 
corresponding to NOEC for the individual compound. In the presence of this mixture, 
the nuclear translocation of zebrafish androgen receptor induced by 6nM 11-KT was 
not significantly inhibited, even though a 7.23% decrease of nuclear translocation of 
zfAR was observed. This inhibition percentage is quite similar to the case observed 
with each single chemical. The second mixture (Mix 2) consists of 10-6M BPA, 10-6M 
p, p’-DDE, 5x10-7M vinclozolin, and 5x10-7M fenitrothion, corresponding to LOEC 
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for the individual compound. A 22.38% inhibition of 11-KT induced nuclear 
translocation was observed. Compared to the inhibition by each single chemical, the 
mixture effect is larger but not enough to conclude cumulative effects from its single 
component.  
Table 4#. Inhibition of nuclear translocation by single chemicals and mixture 1 
* Mix1: mixture of 5x10-7M BPA, 5x10-7M p, p’-DDE, 10-7M vinclozolin, and 10-7M fenitrothion.  
 
Table 5#. Inhibition of nuclear translocation by single chemicals and mixture 2 
* Mix2: mixture of 10-6M BPA, 10-6M p, p’-DDE, 5x10-7M vinclozolin, and 5x10-7M fenitrothion  
++ : indicates statistically significance (P< 0,01, student’s t-test, two-tailed) 
# Results of inhibition caused by single chemical are average of 2-3 repeats, whereas results of 
mixture effects are based on 2 repeats.  
 
6nM 
11-KT 
BPA 
5x10-7M 
p,p’-DDE 
5x10-7M 
Vinclozolin 
10-7M 
Fenitrothion 
10-7M 
Mix 1* 
Nuclear 
Translocation 
percent 
87.54% 
±5.79% 
83.42% 
±1.83% 
81.29% 
±0.47% 
84.19% 
±2.57% 
84.20% 
±2.69% 
81.21% 
±2.68% 
Inhibition percent 0% 4.71% 7.14% 3.82% 3.82% 7.23% 
 
6nM 
11-KT 
BPA 
10-6M 
p, p’-DDE 
10-6M 
Vinclozolin 
5x10-7M 
Fenitrothion 
5x10-7M 
Mix 2* 
Nuclear 
Translocation 
percent 
87.54% 
±5.79% 
75.01% 
±5.66% 
74.86% 
±5.10% 
70.34% 
±5.21% 
76.28% 
±4.22% 
67.94%
++
 
±1.85% 
Inhibition percent 0% 14.31% 14.48% 19.64% 12.85% 22.38% 
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Discussion 
Subcellular localization of zfAR upon exposure to 11-KT 
The use of YFP tagged zfAR allows image analysis of living cells to determine the 
subcellular localization of zfAR in response to ligand exposure. The results showed 
that in Hela cells 40% to 50% of the unliganded zfAR population located in nuclei 
while the rest located in cytoplasm. This pattern is different from that inferred from 
the hAR model in which unliganded human androgen receptor resides largely in the 
cytoplasm, complexed with heat shock proteins (Kumar et al. 2006). The presence of 
unliganded zfAR in both nucleus and cytoplasm might be correct, but it may also be 
the result of experimental variances such as overexpression of the protein in 
transiently transfected cells. Contradictory conclusions have also been presented for 
human AR, even though the consensus has been reached after applying sophisticated 
techniques and refinement of the previous studies. Jenster et al (1993) studied the 
subcellular localization of human AR by immunostaining within different cell lines 
where hAR was transiently expressed. A cell line specific subcellular distribution of 
the unliganded receptor was reported. hAR expressed in Hela cells was predominantly 
nuclear, whereas mainly cytoplasmic staining was observed when it was expressed in 
the monkey kidney cells COS-1 (Jenster et al. 1993). The author attributed this cell 
line specific observation to the differences in membrane-translocation efficiency and 
the components involved in trapping the AR within each cell line. Hereafter, 
subcellular localization of unliganded human AR have been studied in monkey kidney 
cells COS-1, COS-7, prostate cancer cells PC3 and Hela cells (Georget et al. 1997; 
Marcelli et al. 2006; Saporita et al. 2003; Tomura et al. 2001). hAR distributed 
exclusively in cytoplasm in the absence of agonists in COS-1, COS-7 and PC3 cells, 
while Hela cells expressing GFP-hAR did not show exclusively cytoplasmic 
distribution of the protein (Marcelli et al. 2006). Thus, the cell line specific 
distribution of unliganded hAR might also apply to zfAR. However, a 
ligand-regulated nuclear export signal (NES) in human androgen receptor was later 
 58
identified and it is reported to be dominant over the NLS in the DNA binding domain 
(Saporita et al. 2003), meaning that in the absence of agonists, the NES is sufficient to 
keep hAR cytoplasmic even with a coexisting intact NLS. This makes it more difficult 
to explain the nuclear import of hAR in Hela cells when androgen is absent. In 
addition, another possible explanation for the observed nuclear distribution of zfAR 
could be that trace amounts of steroids in the serum used in cell culturing might be 
able to induce zfAR translocation since the requiring concentration of agonist is 
extremely low (as low as 1nM). However, since serum is used in culturing all the cell 
lines mentioned above, this explanation seems invalid. But it would still be interesting 
to investigate the localization of zfAR in Hela cells grown in serum-free medium 
because zfAR may be more sensitive to agonists. Further, phenol red in the cell 
culture medium is a weak estrogen (Berthois et al. 1986), and since cross reaction of 
estrogens with androgen receptor has been reported (Marcelli et al. 2006; Roy et al. 
2001), phenol red may also contribute to the high background of nuclear fluorescence.  
Upon ligand exposure, zfAR was translocated into nucleus efficiently in a 
dose-dependent manner. The observed nuclear transportation of zfAR in response to 
11-KT agrees well with the previous observation in human androgen receptor 
(Georget et al. 1997; Jenster et al. 1993; Kumar et al. 2006; Marcelli et al. 2006; 
Saitoh et al. 2002; Tyagi et al. 2000; Whitaker et al. 2004; Zhou et al. 1994). 
According to the studies with hAR, nuclear import of hAR occurs within 10-30 
minutes, with concomitant formation of punctuated foci in the nuclei (Georget et al. 
1997; Marcelli et al. 2006). However, due to the experimental setup in this project 
where 11-KT was added at the time of transfection, a real time imaging analysis of the 
nuclear translocation of zfAR was not conducted. In a pilot experiment, 11-KT was 
added at 24 hours after transfection, and pictures were taken at time 0, 10 min, 20min, 
30 min, 45min and 1hour. Because a single cell was followed in the experiment, the 
cell culture was placed under the microscope at room temperature without supply of 
5% CO2. After 1 hour, even though a slight redistribution of fluorescence did occur, 
no clear sign of nuclear translocation of YFP-zfAR was observed (pictures not shown). 
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The suboptimal physiological condition, i.e. low temperature, low pH, could inhibit 
the normally efficient nuclear import. Nucleus foci were not observed because of the 
limited quality of the pictures taken. But due to the seemingly similar androgen 
signaling mediated by zfAR and hAR, zfAR is speculated to locate in special 
subnuclear compartments in association with genes being expression regulated by 
zfAR. By applying sophisticated cell biological and molecular approaches, a highly 
dynamic picture of how hAR and its partners mediate gene expression is emerging, 
and this may be highly informative for the future study of androgen signaling in 
zebrafish. 
Site-directed mutagenesis of the putative NLS within zfAR revealed that the import of 
zfAR is mediated through a bipartite sequence that span the DNA binding and the 
hinge regions. The sequence KKCFEVGMTLGARKLRK, consists of two clusters of 
basic amino acids (underlined) that facilitate zfAR nuclear import. Replacement or 
deletion of the amino acids in either of the two regions severely damaged the nuclear 
transfer of zfAR induced by 11-KT exposure. The main reason for the failure of 
nuclear import of zfAR could be that the NLS recognition and/or interaction with the 
importins were damaged. In addition, mutations in the NLS may also interfere with 
other critical steps in the nuclear import process. Conformational changes of the 
protein resulting from amino acid changes may influence the ligand recognition of the 
LBD, phosphorylation of the receptor upon ligand binding, dimerization of the 
receptor or a combination of those steps. However, some certain extent of nuclear 
import of zfAR still remained, especially in mutant 1 whose Lys-Lys in NLS were 
replaced by Gly-Ala, while Arg-Lys-Leu-Arg-Lys remains intact. This indicates that 
even though the Lys-Lys play an important role in the nuclear import process, the 
Arg-Lys-Leu-Arg-Lys sequence can function independently to a certain extent. The 
Lys-Lys do not seem to induce nuclear import independently because the nuclear 
translocation percentage observed in mutant 4 zfARK583R585K586M was not higher than 
that observed in the double mutant 5 zfARK570G, K571A, del582-586. In fact, mutant 4 
zfARK583R585K586M seems to have the lowest nuclear translocation, even though less 
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conformational change is expected as the changes in amino acids in mutant 4 
zfARK583R585K586M were relatively few, both regarding the number of amino acids, and 
the size of amino acids. In mutant 4, the wild type NLS KK…RKLRK was changed to 
KK…RMLMM, and therefore only three amino acids were changed and the sizes of 
M and R/K are similar. Thus the less nuclear translocation observed with mutant 4 
leads to the conclusion that failure of nuclear import is rather because of the 
interference in NLS recognition and/or interaction with the import machinery than 
because of significant change in the protein conformation.  
Further, around 20% of the zfAR mutated in the second basic region tend to locate in 
the nucleus, and two explanations are proposed based the analogy to hAR and hGR 
(human glucocorticoid receptor). The first explanation is that there might be another 
NLS in the LBD of zfAR. A second ligand-dependent NLS has been identified in the 
LBD of GR in addition to the NLS in the DBD and the hinge region (Picard and 
Yamamoto 1987). Similarly, a ligand-dependent NLS also exists in the LBD of hAR, 
which is capable of inducing nuclear import in the absence of the NLS in the DBD 
and hinge region (Jenster et al. 1992; Poukka et al. 2000; Saporita et al. 2003). 
Because the LBD of AR is a highly conserved domain, it is likely that a similar NLS 
also exist in zfAR. The second explanation could be that a possible nuclear export 
signal (NES) in the LBD of zfAR was disrupted due to the mutations. A 
ligand-dependent NES was identified in the LBD of hAR and in the absence of 
agonist, the active NES dominate over the NLS and keep the AR in cytoplasm, 
whereas ligand exposure inactivate the NES and results in nuclear import of AR 
mediated by NLS (Saporita et al. 2003). Mutations in the hinge area of AR may cause 
conformational change of the protein thus interfering with the repression of NES by 
the agonist and leading to leakage of AR into the nucleus. A putative NES in the LBD 
of zfAR has been predicted by ClustalW (figure 16), and therefore it is plausible that 
the conformational changes resulting from mutations in NLS indirectly leads to 
nuclear import of zfAR. This theory is also consistent with the results where the 
mutants (except zfARK570G, K571A) with more significant changes in amino acids had 
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higher nuclear translocation percentage in the presence of 11-KT.  
Nuclear export sequence 
                              ++   +  +           +                  +   +  
Homo sapiens AR(731-792) LMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMKHLSQEFVLLQVTQEEFL  
Danio rerio AR(694-755)  MMVFALGWRSYKNANARMLYFAPDLVFNDRRMHVSSMYEHCVQMRHLSQEFGWLQITPQEFL  
                              :****:****:.*.*:************: *** * **.:**:*:******  **:* :*** 
 
Homo sapiens AR(793-799) CMKALLL  
Danio rerio AR (756-762) CMKAMLL  
****:** 
Figure 17. Androgen receptor sequence alignment of the ligand bindind domain of Homo 
sapiens and Danio rerio. Nuclear export sequence identified in Homo sapiens is used. The 
sequence homology and similarity of NES was determined using ClustalW analysis. * identical 
residues between the ARs, : highly conserved residues, . semi-conserved amino acids, + 
residues that interact with the ligand. 
Another observation worth noticing is the formation of receptor clusters (represented 
by the green dots in the pictures) in cells expressing zfAR mutants especially mutants 
with the replacement of the Lys-Lys with Gly-Ala in the first basic domain of NLS 
which overlaps the DBD. This is mainly seen when 11-KT is added, particularly when 
10nM 11-KT is present. The formation of intracellular punctuated foci in response to 
10nM 11-KT is not very likely to be a sign of degradation of the protein since no such 
foci have been observed in the cells untreated with 11-KT and it is rarely seen in cells 
treated with 1nM 11-KT. Similar receptor clusters formation in response to ligand 
adding has also been reported in hAR with mutations in the DBD (Jenster et al. 1993; 
Marcelli et al. 2006). No clear explanation was provided in any of the articles, but an 
indication of alteration of the DBD function was suggested. A future experiment 
intending to investigate whether the formation of receptor cluster is associated with 
cell apoptosis would be interesting.  
Subcellular localization of zfAR upon exposure to ADCs 
Subcellular localizations of YFP-zfAR in the presence of four antiandrogens over a 
range from 10-9M to 10-5M with/without co-treatment of 6nM 11-KT were analyzed. 
None of the four compounds alone induced nuclear translocation of zfAR, except that 
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10-9M BPA caused around 80% of the zfAR translocation and 10-5M vinclozolin also 
showed a slight induction of nuclear translocation of zfAR. Co-treatment of cells with 
the antiandrogen and 6nM 11-KT resulted in inhibition of nuclear translocation of 
zfAR in a dose-response manner.  
BPA is believed to be an androgen antagonist that can affect multiple steps in the 
activation and function of human AR, including inhibiting the binding of native 
androgens to AR, AR nuclear localization, AR interaction with coregulators, and its 
subsequent transactivation (Lee et al. 2003). At concentration from 10-8M to 10-5M, 
BPA did not induce nuclear translocation of zfAR which is similar to result from the 
human androgen receptor (Tomura et al. 2001). BPA was also reported to maximally 
inhibit DHT binding to androgen receptor at concentration 50nM and the inhibition is 
non-competitive (Lee et al. 2003). This may indicate another distinct interaction site 
between BPA and the androgen receptor other than the ligand binding pocket. This 
may be a potential explanation for the observed nuclear translocation of zfAR 
induced by 10-9M BPA. Treatment of cells with BPA in the presence of 6nM 11-KT 
revealed a failure of nuclear import of zfAR. Significant decrease in nuclear 
translocation occurred at 1µM and a maximum inhibition effect was observed at 5µM. 
Inconsistent results have been reported with human AR. Lee et al. (2003) observed 
that the nuclear translocation of GFP-hAR fusion protein in the presence of 
testosterone was affected by the addition of 10µM BPA, while Tomura et al. (2001) 
showed that co-treatment of cells with 1µM of BPA and 10nM DHT preserved 
DHT-induced fluorescence focus formations in the nucleus. Concentration difference 
in these two tests probably contributes to the contradictory results, since a dramatic 
inhibition of nuclear translocation of AR was seen as the concentration of BPA 
increase from 1µM to 5µM in the present study.  
In contrast to the observation in this project that vinclozolin and p, p’-DDE did not 
induce nuclear translocation of zfAR, these two antiandrogens were found to 
successfully promote nuclear import of human AR at concentration of 1µM (Roy et al. 
2001; Tomura et al. 2001). Pure antiandrogens such as hydroxyflutamide (OHF) and 
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bicalutamide (CAS) are examples of antiandrogens that does not destroy nuclear 
translocation of hAR (Marcelli et al. 2006; Poukka et al. 2000; Tomura et al. 2001; 
Tyagi et al. 2000), however, they were usually much slower and less effective than the 
natural ligands (Poukka et al. 2000). This group of nonhormonal ligands elicit their 
antiandrogenic effects by inhibiting the subsequent steps that result in AR 
transactivation (Marcelli et al. 2006; Poukka et al. 2000; Tomura et al. 2001; Tyagi et 
al. 2000), and they were also found to disrupt the formation of nuclear foci induced 
by DHT (Tomura et al. 2001). However, in our zebrafish model, the interaction of 
zfAR with vinclozolin and p, p’-DDE failed to induce the first step, namely the 
import of AR into the nuclear compartment, and it also inhibit the interaction between 
11-KT and the androgen receptor. Even though vinclozolin in the concentration 10-5M 
showed a slight induction of nuclear translocation of zfAR, the dramatic inhibition of 
11-KT action indicate a different effect than what was seen in the hAR. This may 
indicate that the two chemicals interact with zfAR and hAR in distinct manners.  
Fenitrothion showed similar results as vinclozolin and p, p’-DDE. It is previously 
demonstrated to competitively antagonize DHT-dependent hAR activation (Tamura et 
al. 2001). However, no study has previously investigated the subcellular localization 
of AR in the presence of fenitrothion. Thus, this is the first time that fenitrothion is 
reported to affect the androgen signaling of zfAR at its nuclear translocation level. 
Other examples of antiandrogens that have been shown to cause nuclear translocation 
failure include agriculture fungicide procymidone and chlozolinate (Roy et al. 2001). 
Binding of agonists to hAR is known to induce conformational changes of the AR 
resulting in dissociation of AR with its chaperon protein and altered interactions 
between the N and C-termini because of the repositioning of helix 12 in the LDB 
(Roy et al. 2001). Thus the suggested mechanism for the mode of action for this 
group of antiandrogens is that the conformational transition induced by these 
chemicals is inadequate for dissociation of the receptor from other cytoplasmic 
proteins and/or exposure of the NLS to promote its interaction with importins for its 
nuclear import (Roy et al. 2001). Other steps critical for the nuclear transportation 
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may also be disrupted, such as the phosphorylation of the receptor upon ligand 
binding and the dimerization of receptor. 
Due to the nonparallel dose-response curve in inhibiting 11-KT induced nuclear 
translocation of zfAR, potency of the four antiandrogens is hard to compare based on 
the present results. However, according to the LOECs, vinclozolin is the most potent 
antiandrogen among the four. This is in agreement with previous results. In a 
screening of chemicals for anti-androgenic activity based on inhibition of luciferase 
activity induced by R1881, vinclozolin was the most potent antiandrogenic compound 
among the others including bisphenol A and p, p’-DDE (Roy et al. 2004). Gray et al. 
(1999) also demonstrate that p, p’-DDE is a less potent AR ligand compared to 
vinclozolin. In another study, the potency of fenitrothion to competitively inhibit 
DHT-dependent human androgen receptor activation of the luciferase reporter was 
found to be 8-fold higher than that of p, p’-DDE (Tamura et al. 2001).  
The nonparallel dose-response curve created problems in the study of combinational 
effects of the chemicals, where the toxic equivalency factor (TEF) approach is 
generally used to derive the mixture ratio. However, in this study the TEF vary 
depending on the effect level chosen for deriving their numerical values. Therefore 
the mixture ratio of the four chemicals used to test the combination effects was 
derived from the NOEC and LOEC of the individual compounds. Even though there 
were compelling evidences that the combination effects of antiandrogens are dose 
additive regardless of the mode of actions, this conclusion could not be verified in this 
study. The theory for the cumulative effects from a mixture of antiandrogens that have 
distinct mode of actions is that even though the chemicals are acting independently at 
a molecular and cellular level, they all target a common pathway, the androgen 
signaling pathway. Measurement of endpoints that are far downstream from the 
biochemical mechanisms of the individual chemicals can not distinguish decreased 
androgen signaling resulting from testosterone synthesis inhibition and that resulting 
from antagonists binding to ARs (Rider et al. 2008). In this project, a single step in 
the androgen signaling pathway is measured as endpoint, even though many events 
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have to proceed to allow this step to occur. However, nuclear translocation of zfAR 
can still be seen as a common target since the single chemical experiments showed 
that all four chemicals disrupted 11-KT induced nuclear transport regardless of which 
step(s) they may affect. 
The potential dose addition effects of the mixture with each of its component at their 
NOEC were probably not large enough to be detected because of insufficient number 
of test chemicals. Eight and seven chemicals were used in two of the well-known 
mixture effects studies where “something from nothing” was reported (Rider et al. 
2008; Silva et al. 2002). For the mixture in which each of the components was at the 
concentration of its LOEC, a higher inhibition of nuclear translocation was observed 
with the mixture compared to that with single chemical. However, it still does not 
seem to be high enough to be concluded as dose additive. Limiting resolving power of 
the present method may have eliminated the chance to make this conclusion. The 
method used in this project is far from the ideal way for acquiring statistically 
relevant data at the single cell level, since it is operator-dependent and laborious. 
Therefore, it was not realistic to include single chemical controls in every repeat of 
the mixture experiments. Combinational effects had to be compared with single 
chemical effects that were observed in previous experiments. Because of the variance 
resulting from the expression level of the protein, transfection efficiency, the high 
background nuclear fluorescence in Hela cells, and the inevitable changing criteria of 
the picture analyzer etc, changes of fluorescence partitioning between nucleus and 
cytoplasm were sometimes not easy to reach a statistically significant level. High 
throughput microscopy that can analyze thousands of cells from a 96-well plate was 
used in a study of the quantifying effects of ligands on androgen receptor nuclear 
translocation, intranuclear dynamics and solubility (Marcelli et al. 2006). This 
approach seems to be an extremely powerful technology for single cell analysis.  
For future research, it will be interesting to clearly describe the mechanism of action 
of the four antiandrogens in inhibiting discrete step in androgen actions. Competitive 
binding assays can be conducted to study the binding kinetics of these chemicals to 
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zfAR. Mutagenesis in the LBD of zfAR can reveal more details about the interaction 
between ligands and zfAR. For vinclozolin and p, p’-DDE comparative studies 
between human AR and zfAR could be interesting to determine why they do not 
interfere with nuclear translocation of hAR but dose interfere with the zfAR. Further 
analysis is needed to clearly describe the details in interaction between the antagonists 
and the androgen receptor, which could be conducted by structure-function analysis. 
A method with higher resolving power should be used to study the mixture effects 
where highly quantitative data are required for accurate prediction. 
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Conclusion 
By using a YFP-zfAR fusion protein, zfAR was found to undergo nuclear 
translocation in response to DHT and 11-KT. Site-directed mutagenesis of a predicted 
NLS within zfAR revealed that this nuclear import is mainly mediated through a 
bipartite type of NLS (KKCFEVGMTLGARKLRK) ranging from the DBD to the 
hinge region of zfAR. Both the first and the second clusters of basic amino acids 
(underlined) in the NLS are important in recognizing and/or interacting with the 
import machinery, but the second domain seems more essential than the first basic 
domain. 
By measuring the nuclear translocation of zebrafish androgen receptor as the major 
endpoint, the four environmental chemicals, BPA, p, p’-DDE, vinclozolin and 
fenitrothion, which have been previously demonstrated to be antiandrogens in 
mammalian, were shown also to elicit androgen antagonistic effects in our in vitro 
system with zebrafish. The action of 11-KT was inhibited by these four antiandrogens 
in a dose-response manner. Interestingly, p, p’-DDE and vinclozolin, that do not 
disrupt hAR nuclear translocation, seem to strongly inhibit this step in zfAR action. 
Mixture effects of these four chemicals were larger than effects observed with the 
single chemicals, but no cumulative effects can be concluded from this study.  
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